It’s rejected a pair of drugs in the last six months.
News & Analysis: AstraZeneca
They're flying high right now. But are these three healthcare stocks smart picks?
These industry giants could make big moves after this year's World Conference on Lung Cancer.
The fight against cancer is a big battle. And these 10 companies are among the biggest combatants you can invest in.
Solid earnings lifted some stocks despite a big market downturn.
These three diabetes stocks should be on your radar right now.
Look past the surface for these strong contenders.
These A-list drugmakers must both contend with expiring patents, new drug uncertainties, and hungry competitors. But they're in different stages of their cyclical journeys.
AZN earnings call for the period ending March 31, 2019.
Deals, downgrades, and disappointing earnings led to losses for these stocks.